Rallybio RLYB
NASDAQ RLYB
$16.55 -0.05 (-0.30%)
As of: Aug 21, 2026 · 11:43 AM EDT

Rallybio (RLYB) EBT Margin (2024 - 2026)

Rallybio (RLYB) posted EBT Margin of 3904.72% for Q1 2026, down 48.13% sequentially from 2636.04% in Q4 2025, and up 27075.0% YoY from N/an in Q1 2025.

Rallybio (RLYB) EBT Margin (2024 - 2026) Analysis & Trends

Rallybio has reported EBT Margin for 3 years, with the latest figure at 3904.72% in Q1 2026.

  • Quarterly EBT Margin rose 27075.0% year-over-year to 3904.72% in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 877.62% (up 455209.0% YoY) and the FY2025 annual result came in at 944.52%, up 778755.0% from the prior year.
  • EBT Margin declined to 3904.72% in Q1 2026 per RLYB's latest filing, from 2636.04% in the prior quarter.
  • Over five years, EBT Margin peaked at 7554.72% in Q3 2025 and troughed at 27931.58% in Q4 2024.
  • A 3-year average of 5552.94% and a median of 4040.09% in 2025 frame the typical range for EBT Margin.
  • The sharpest annual moves came in 2025 and 2026: EBT Margin surged 2529554 bps in 2025, then jumped 27075 bps in 2026.
  • Over 3 years, EBT Margin stood at 27931.58% in 2024, then jumped by 91 bps to 2636.04% in 2025, then slumped by 48 bps to 3904.72% in 2026.
  • According to Business Quant data, EBT Margin over the past three periods registered 3904.72%, 2636.04%, and 7554.72% for Q1 2026, Q4 2025, and Q3 2025 respectively.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EBT Margin (Qtr)
1 Vertex Pharmaceuticals 139.71 Bn 131.86 Bn 2.84 Bn 41.75%
2 Regeneron Pharmaceuticals 86.55 Bn 78.55 Bn 3.93 Bn 35.61%
3 Argenx Se 65.26 Bn 60.07 Bn 1.37 Bn 35.71%
4 Moderna 59.81 Bn 54.67 Bn 52.00 Mn -528.97%
5 BeOne Medicines 42.16 Bn 37.06 Bn 1.53 Bn 18.33%
6 Alnylam Pharmaceuticals 31.87 Bn 28.56 Bn 992.69 Mn 13.77%
7 BioNTech SE 28.13 Bn 9.74 Bn 668.28 Mn -25.06%
8 Insmed 27.53 Bn 26.37 Bn 358.27 Mn -2.67%
9 Royalty Pharma 27.31 Bn 26.47 Bn - 12.09%
10 Rallybio 94.32 Mn 94.32 Mn - -

Historic Data

Download Data
DateValue
Mar 31, 2026 -3,904.72%
Dec 31, 2025 -2,636.04%
Sep 30, 2025 7,554.72%
Jun 30, 2025 -4,441.51%
Mar 31, 2025 -4,175.47%
Dec 31, 2024 -27,931.58%
Sep 30, 2024 -3,621.74%
Jun 30, 2024 -5,267.22%